Gordon L Phillips

Gordon L Phillips

UNVERIFIED PROFILE

Are you Gordon L Phillips?   Register this Author

Register author
Gordon L Phillips

Gordon L Phillips

Publications by authors named "Gordon L Phillips"

Are you Gordon L Phillips?   Register this Author

27Publications

462Reads

32Profile Views

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.

Cancer Med 2016 11 3;5(11):3059-3067. Epub 2016 Oct 3.

James P Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, Rochester, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119960PMC
November 2016

The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.

Biol Blood Marrow Transplant 2016 Apr 26;22(4):605-616. Epub 2015 Sep 26.

Division of Hematology, Blood & Marrow Transplantation, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.014DOI Listing
April 2016

A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.

Biol Blood Marrow Transplant 2013 Dec 8;19(12):1745-52. Epub 2013 Oct 8.

Department of Medicine, Hematology/Oncology Division, University of Rochester Medical Center, Rochester, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.10.002DOI Listing
December 2013

A phase I study of decitabine and rapamycin in relapsed/refractory AML.

Leuk Res 2013 Dec 8;37(12):1622-7. Epub 2013 Sep 8.

Department of Medicine, Division of Hematology/Oncology, University of Rochester, Rochester, NY 14642, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.09.002DOI Listing
December 2013

Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): how can we improve outcomes in the near future?

Leuk Res 2012 Dec 3;36(12):1490-5. Epub 2012 Sep 3.

Hematology/Oncology, Blood and Marrow Transplant Program, JP Wilmot Cancer Center, University of Rochester Medical Center, Strong Memorial Hospital, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.08.004DOI Listing
December 2012

Platelets--to transfuse or not to transfuse.

Lancet 2012 Oct 8;380(9850):1287-9. Epub 2012 Aug 8.

Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(12)60983-0DOI Listing
October 2012

Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.

Am J Hematol 2012 Jul 10;87(7):743-5. Epub 2012 May 10.

Department of Internal Medicine, University of Rochester Medical Center, Rochester, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23225DOI Listing
July 2012

Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease.

Am J Hematol 2011 Aug 31;86(8):712-4. Epub 2011 May 31.

Pathology and Laboratory Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22075DOI Listing
August 2011

A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.

Biol Blood Marrow Transplant 2011 Jul 11;17(7):1033-42. Epub 2010 Nov 11.

Hematology Oncology, University of Rochester Medical Center, James P. Wilmot Cancer Center, Strong Memorial Hospital, Rochester, New York 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.11.003DOI Listing
July 2011

Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma.

Cancer Treat Res 2009 ;144:357-97

Department of Internal Medicine, Section of Oncology-Hematology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198-7680, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-78580-6_15DOI Listing
September 2010

How do we define cure of diabetes?

Diabetes Care 2009 Nov;32(11):2133-5

Division of Endocrinology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc09-9036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768219PMC
November 2009

Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma.

Int J Radiat Oncol Biol Phys 2009 Sep 26;75(1):188-92. Epub 2009 Feb 26.

Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.10.048DOI Listing
September 2009

High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later.

J Clin Oncol 2008 May;26(14):2240-3

Department of Medicine, University Hospitals Case Medical Center, Ireland Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2007.14.7827
Publisher Site
http://dx.doi.org/10.1200/JCO.2007.14.7827DOI Listing
May 2008

The hematopoietic stem cell in myelodysplasia.

Stem Cells 2004 ;22(4):590-9

Leukemia/Blood and Marrow Transplant Program, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/stemcells.22-4-590DOI Listing
March 2005

Tandem transplantation in multiple myeloma.

Oncology (Williston Park) 2003 Mar;17(3):389-98; discussion 398-400, 405-7

Bone Marrow Transplant Program, University of Maryland, Greenebaum Cancer Center, Blood and Marrow Transplant Program, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
March 2003

The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation.

Semin Oncol 2002 Dec;29(6 Suppl 19):53-6

Leukemia/Blood and Marrow Transplantation Program, Wilmot Cancer Center, University of Rochester School of Medicine, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2002.37367DOI Listing
December 2002